Vertex Pharmaceuticals Inc.
[WKN: 882807 | ISIN: US92532F1003]
Aktienkurse
462,070$ 2,46%
Echtzeit-Aktienkurs Vertex Pharmaceuticals Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Vertex Pharmaceuticals: Kursziel gesenkt

Boston (www.aktiencheck.de) - Rating-Update: David Risinger, Analyst von SVB Securities, stuft die Aktie des Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN…

Vertex Pharmaceuticals: Kursziel angehoben

London (www.aktiencheck.de) - Rating-Update: Gena Wang, Analystin von Barclays, bewertet die Aktie des US-Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN…

The Latest Analyst Ratings for Vertex Pharmaceuticals

Latest Ratings for VRTX DateFirmActionFromTo Feb 2022RBC CapitalDowngradesOutperformSector Perform Jan 2022BMO CapitalUpgradesMarket PerformOutperform Dec 2021Wells FargoInitiates Coverage OnOverweight …

Vertex Pharmaceuticals: Hochstufung

Boston (www.aktiencheck.de) - Rating-Update: David Risinger, Analyst von SVB Securities, stuft die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN…

Vertex Pharmaceuticals: Downgrade

New York (www.aktiencheck.de) - Rating-Update: Michael Yee, Analyst von Jefferies & Co, stuft die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…